AN IN-SILICO STUDY OF ANDALIMAN (Zanthoxylum acanthopodium DC.) AS AN ANTICANCER AGENT AGAINST TYROSINE KINASE ENZYME INHIBITION USING THE DOCKING METHOD: IN SILICO MOLECULAR DOCKING STUDY OF ACTIVE COMPOUNDS FROM ANDALIMAN (Zanthoxylum acanthopodium DC.) AGAINST TYROSINE KINASE ENZYME AS AN ANTICANCER AGENT. fj [Internet]. 2026 July 15 [cited 2026 Nov. 13];6(1):348-72. Available from: https://ojs.unhaj.ac.id/index.php/fj/article/view/2155